VEGFR2 plays a crucial role in angiogenesis through activating the MAPK and PI3K signaling pathways, which in turn activate downstream ERK1/2 or mTOR ligands, leading to tumor growth and angiogenesis. This evidence concerns the gene MTOR and neoplasm.